<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="81836">
  <stage>Registered</stage>
  <submitdate>1/02/2007</submitdate>
  <approvaldate>21/01/2009</approvaldate>
  <actrnumber>ACTRN12609000047291</actrnumber>
  <trial_identification>
    <studytitle>The acceptability and effectiveness of chocolate or tomato extract in reducing blood pressure in people with pre-hypertension: a pilot study.</studytitle>
    <scientifictitle>In people with pre-hypertension, how acceptable and effective are chocolate and tomato extract compared to placebo in reducing blood pressure?</scientifictitle>
    <utrn />
    <trialacronym>na</trialacronym>
    <secondaryid>na</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Pre-hypertension</healthcondition>
    <conditioncode>
      <conditioncode1>Cardiovascular</conditioncode1>
      <conditioncode2>Hypertension</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Cardiovascular</conditioncode1>
      <conditioncode2>Coronary heart disease</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Intervention 1: 50G of 70% cocoa chocolate orally daily for 2 months
Intervention 2: One capsule of Lyc-o-Mato tomato extract containing 15mg lycopene orally daily for 2 months</interventions>
    <comparator>3. Placebo capsule matching in size, colour and smell the active treatment capsule containing soy oil orally daily for 2 months</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Acceptability of each treatment using questionnaires</outcome>
      <timepoint>at 8 and 20 weeks</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Reduction in blood pressure</outcome>
      <timepoint>at 0, 4, 8, 12, 16, 20, 24 weeks</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>physical activity by questionnaire</outcome>
      <timepoint>0,8,20 weeks</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>general health, mood, energy by questionnaire</outcome>
      <timepoint>0,8,20 weeks</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Blood pressure 120-139/80-89 mm Hg</inclusivecriteria>
    <inclusiveminage>20</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>Currently on treatment for hypertension;
Diabetic or glucose intolerant;
Allergic to or intolerant of tomato or cocoa</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Possible participants identified by general practitioner or nurse and invited to participate, screened for inclusion and exclusion criteria, enrolled into trial if criteria met.  Randomly assigned to one of the three experimental groups.  Allocation was concealed by computer generated random number tables conducted by a statistician off-site and not involved in the trial.</concealment>
    <sequence>Computer generated random number table</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures>Blinding was assured for participants taking a  capsule, either tomato extract or placebo. However, blinding of participants allocated to a chocolate group was impractical. IThe research nurse who assessed outcomes and investigators analysing data were blinded for all treatment groups.</designfeatures>
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>1/04/2007</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>60</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Dr Oliver Frank</primarysponsorname>
    <primarysponsoraddress>Discipline of General Practice
THe University of Adelaide
Adelaide SA 5005</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>Royal Australian College of General Practitioners (RACGP)</fundingname>
      <fundingaddress>Royal Australian College of General Practitioners (RACGP) 
College House, 1 Palmerston Cresent
Melbourne VIC 3205</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Dr Karin Ried</sponsorname>
      <sponsoraddress>Discipline of General Practice
THe University of Adelaide
Adelaide SA 5005</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>Prof Nigel Stocks</othercollaboratorname>
      <othercollaboratoraddress>Discipline of General Practice
THe University of Adelaide
Adelaide SA 5005</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This study will seek to find out whether cocoa (chocolate) or tomato extract are acceptable to take and effective in reducing the blood pressure of people with blood pressure in the prehypertensive range (80-89 /120-139 mm Hg).</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Human Research Ethics Committee University of Adelaide</ethicname>
      <ethicaddress />
      <ethicapprovaldate>1/03/2007</ethicapprovaldate>
      <hrec>H-015-2007</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr. Karin Ried</name>
      <address>Discipline of General Practice
School of Population Health and Clinical Practice
Faculty of Health Sciences
University of Adelaide
SA 5005</address>
      <phone>+61 8 8303 6281</phone>
      <fax>+61 8 8303 3511</fax>
      <email>karin.ried@adelaide.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr. Karin Ried</name>
      <address>Discipline of General Practice
School of Population Health and Clinical Practice
Faculty of Health Sciences
University of Adelaide
SA 5005</address>
      <phone>+61 8 8303 6281</phone>
      <fax>+61 8 8303 3511</fax>
      <email>karin.ried@adelaide.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr. Karin Ried</name>
      <address>Discipline of General Practice
The University of Adelaide</address>
      <phone />
      <fax />
      <email>karin.ried@adelaide.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>